Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Idiopathic environmental intolerance, Insomnia, Loss of personal independence in daily activities, Paraesthesia
Clinical narrative: pins and needles sensation/prickling; entire body has become hyper sensitive to energy emissions from all types of electronics and wi-fi; cannot sleep; quit my office job/quality of life is terrible; extreme full body discomfort; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on 18Apr2022 as dose number 4 (booster), single (Lot number: FJ4991) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sjogren's" (unspecified if ongoing); "bipolar 2" (unspecified if ongoing), notes: bipolar 2; "mild distal peripheral neuropathy in my feet" (unspecified if ongoing), notes: mild distal peripheral neuropathy in my feet. Concomitant medication(s) included: LAMOTRIGINE; KLONOPIN; ELAVIL [ALLOPURINOL]; MARIJUANA. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: ER8734, Location of injection: Arm Left), administration date: 25Mar2021, when the patient was 57-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: ER8731, Location of injection: Arm Left), administration date: 17Apr2021, when the patient was 57-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 3, Batch/Lot No: FH8020, Location of injection: Arm Left), administration date: 17Oct2021, when the patient was 58-year-old, for COVID-19 immunization. The following information was reported: INSOMNIA (disability) with onset 20Apr2022, outcome "not recovered", described as "cannot sleep"; IDIOPATHIC ENVIRONMENTAL INTOLERANCE (disability) with onset 20Apr2022, outcome "not recovered", described as "entire body has become hyper sensitive to energy emissions from all types of electronics and wi-fi"; DISCOMFORT (disability) with onset 20Apr2022, outcome "not recovered", described as "extreme full body discomfort"; PARAESTHESIA (disability) with onset 20Apr2022, outcome "not recovered", described as "pins and needles sensation/prickling"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (disability) with onset 20Apr2022, outcome "not recovered", described as "quit my office job/quality of life is terrible". The events "pins and needles sensation/prickling" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown, notes: Since the vaccination, has the patient been tested for COVID-19?:Yes; Negative, notes: Negative. Therapeutic measures were not taken as a result of paraesthesia, idiopathic environmental intolerance, insomnia, loss of personal independence in daily activities, discomfort.  Additional information: Within 72 hours of receiving second Pfizer booster on 18Apr2022, pins and needles sensation began in hands when and after holding my cellphone. Since that time, entire body became hyper hypersensitive to energy emissions from all types of electronics and wi-fi, including computers, laptops, cellphones, internet, computerized system in her hybrid car, smart meters, outdoor overhead electrical and cable wires, LED lightbulbs, and even simple electronics such as a floor fan and digital alarm clock. She had to quit office job because she was surrounded by electronics and radio waves that were causing extreme full body discomfort- prickling and pins and needles, even on face, but especially on hands, arms and upper chest. She cannot use electronics at home, and cannot even work at a remote job. She cannot sleep in bed because the high wires attached to her house outside the bedroom caused intense pins and needles all over the body. Her quality of life was terrible. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination.  Since the vaccination, the patient has not been tested for COVID-19.